The overall goal of the Alzheimer's Disease Research Center (ADRC) at Johns Hopkins University (JHU) is to facilitate research in Alzheimer's disease (AD) and related disorders throughout the research community at JHU and associated institutions. The ADRC is comprised of four Cores: a Clinical Core , a Data Management and Statistics Core, a Neuropathology Core, and an Education Core. The cores will work together to provide the infrastructure and resources to the JHU community so that clinical and basic research in AD and related disorders can continue to flourish and expand. In addition, three projects are proposed. The first Project pertains to executive function impairments in subjects with Mild Cognitive Impairment (MCI) and their relation to progression of cognitive decline over time. The second Project pertains to the clinical-pathological-biochemical alterations present in the earliest stage of pathology in the perforant pathway of the medial temporal lobe among individuals who have come to autopsy, and are either normal, meet criteria for MCI, or have mild AD. The third Project will examine neuropathological, neurochemical, and biochemical aspects of synaptic pathology occurring in several lines of behaviorally-characterized transgenic mice. Cooperative studies with investigators at other ADCs and related research institutions will continue to be conducted, including multi-center clinical trials. Data sharing with other investigators in the AD research community will continue through regular submissions to the National Alzheimer Disease Coordinating Center (NACC).

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-25
Application #
7404605
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J4))
Program Officer
Phelps, Creighton H
Project Start
1997-07-15
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
25
Fiscal Year
2008
Total Cost
$1,800,437
Indirect Cost
Name
Johns Hopkins University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Tsapkini, Kyrana; Webster, Kimberly T; Ficek, Bronte N et al. (2018) Electrical brain stimulation in different variants of primary progressive aphasia: A randomized clinical trial. Alzheimers Dement (N Y) 4:461-472
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Riello, Marianna; Faria, Andreia V; Ficek, Bronte et al. (2018) The Role of Language Severity and Education in Explaining Performance on Object and Action Naming in Primary Progressive Aphasia. Front Aging Neurosci 10:346
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Ayhan, Fatma; Perez, Barbara A; Shorrock, Hannah K et al. (2018) SCA8 RAN polySer protein preferentially accumulates in white matter regions and is regulated by eIF3F. EMBO J 37:
Sathe, Gajanan; Na, Chan Hyun; Renuse, Santosh et al. (2018) Phosphotyrosine profiling of human cerebrospinal fluid. Clin Proteomics 15:29
Chen, Lin; Wei, Zhiliang; Chan, Kannie W Y et al. (2018) Protein aggregation linked to Alzheimer's disease revealed by saturation transfer MRI. Neuroimage 188:380-390
Gomez, Gabriela; Beason-Held, Lori L; Bilgel, Murat et al. (2018) Metabolic Syndrome and Amyloid Accumulation in the Aging Brain. J Alzheimers Dis 65:629-639

Showing the most recent 10 out of 830 publications